BRPI0818822A2 - Forma amorfa de um composto anti-inflamatório - Google Patents

Forma amorfa de um composto anti-inflamatório

Info

Publication number
BRPI0818822A2
BRPI0818822A2 BRPI0818822A BRPI0818822A2 BR PI0818822 A2 BRPI0818822 A2 BR PI0818822A2 BR PI0818822 A BRPI0818822 A BR PI0818822A BR PI0818822 A2 BRPI0818822 A2 BR PI0818822A2
Authority
BR
Brazil
Prior art keywords
amorphous form
inflammatory compound
corticosteroid
symptoms
diseases
Prior art date
Application number
Other languages
English (en)
Inventor
Luis Anglada
Carlos Albet
Antonio Guglietta
Original Assignee
Ferrer Int
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int, Nicox Sa filed Critical Ferrer Int
Publication of BRPI0818822A2 publication Critical patent/BRPI0818822A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
BRPI0818822 2007-10-25 2008-10-23 Forma amorfa de um composto anti-inflamatório BRPI0818822A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200702796A ES2324007A1 (es) 2007-10-25 2007-10-25 Una forma amorfa de un compuesto antiinflamatorio.
PCT/EP2008/064387 WO2009053439A2 (en) 2007-10-25 2008-10-23 An amorphous form of an anti-inflammatory compound

Publications (1)

Publication Number Publication Date
BRPI0818822A2 true BRPI0818822A2 (pt) 2015-04-22

Family

ID=40377713

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818822 BRPI0818822A2 (pt) 2007-10-25 2008-10-23 Forma amorfa de um composto anti-inflamatório

Country Status (19)

Country Link
US (1) US20100261691A1 (pt)
EP (1) EP2205620B1 (pt)
JP (1) JP2011500762A (pt)
KR (1) KR20100091159A (pt)
CN (1) CN101861327B (pt)
AT (1) ATE505477T1 (pt)
AU (1) AU2008316471A1 (pt)
BR (1) BRPI0818822A2 (pt)
CA (1) CA2703441A1 (pt)
CY (1) CY1112540T1 (pt)
DE (1) DE602008006244D1 (pt)
DK (1) DK2205620T3 (pt)
ES (2) ES2324007A1 (pt)
MX (1) MX2010004423A (pt)
PL (1) PL2205620T3 (pt)
PT (1) PT2205620E (pt)
RU (1) RU2010120844A (pt)
SI (1) SI2205620T1 (pt)
WO (1) WO2009053439A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2318427T3 (da) * 2008-07-31 2014-01-20 Nicox Sa Glucocorticoider bundet til nitratestere via en aromatisk linker i position 21 og deres anvendelse i oftalmologi
ES2359708B1 (es) * 2009-11-16 2012-03-30 Ferrer Internacional S.A. Procedimiento de preparación de la (11beta,16alfa)-9-fluoro-11-hidroxi-16,17-[1-metil-etilidenebis(oxi)]-21-[1-oxo-[4-(nitrooximetil)benzoxi]]preña-1,4-dien-3,20-diona.
RU2629601C1 (ru) * 2016-11-03 2017-08-30 Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Казанская государственная медицинская академия" Министерства здравоохранения Российской Федерации Способ лечения больных красным плоским лишаем
RU2709534C1 (ru) * 2018-07-12 2019-12-18 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ лечения хронических дерматозов

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1312115B1 (it) * 1999-06-24 2002-04-04 Nicox Sa Composti amorfi e relative composizioni farmaceutiche
US8313504B2 (en) * 2000-09-18 2012-11-20 Cordis Corporation Foam matrix embolization device
ITMI20020148A1 (it) * 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
IL154370A0 (en) * 2003-02-10 2003-09-17 Chemagis Ltd Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same
US20060045850A1 (en) * 2004-08-30 2006-03-02 Qpharma, Llc Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids
EP1940863B1 (en) * 2005-09-02 2012-09-05 Nicox S.A. Nitrooxy derivatives of glucocorticoids

Also Published As

Publication number Publication date
ES2364953T3 (es) 2011-09-19
DE602008006244D1 (de) 2011-05-26
CY1112540T1 (el) 2015-12-09
US20100261691A1 (en) 2010-10-14
DK2205620T3 (da) 2011-07-25
AU2008316471A1 (en) 2009-04-30
CN101861327A (zh) 2010-10-13
RU2010120844A (ru) 2011-11-27
MX2010004423A (es) 2010-09-10
JP2011500762A (ja) 2011-01-06
PT2205620E (pt) 2011-07-12
EP2205620A2 (en) 2010-07-14
ATE505477T1 (de) 2011-04-15
CA2703441A1 (en) 2009-04-30
WO2009053439A2 (en) 2009-04-30
ES2324007A1 (es) 2009-07-28
PL2205620T3 (pl) 2011-10-31
KR20100091159A (ko) 2010-08-18
CN101861327B (zh) 2012-10-31
WO2009053439A3 (en) 2009-07-16
EP2205620B1 (en) 2011-04-13
SI2205620T1 (sl) 2011-08-31

Similar Documents

Publication Publication Date Title
CL2013001654A1 (es) Compuestos derivados de 6-amino-2-fenilamino-1h-bencimidazol-5-carboxamida; composicion farmaceutica; y su uso en el tratamiento y/o prevencion de las enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor.
GT200500360A (es) Compuestos organicos
WO2007093183A3 (en) Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
EP2358378A4 (en) TOPICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY DISEASE, SKIN AND SLAUGHTER DISEASES AND SIMILAR DISEASES
CL2007002641A1 (es) Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos alergicos, autoinmunes, enfermedades inflamatorias.
MX2010002592A (es) Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides.
BR112013019256A2 (pt) inibição de il-17 e ifn-gama para o tratamento de inflamação autoimune
EP2418200A4 (en) PHTHALIAMIDE DERIVATIVES FROM NON-SERIOUS ANTI-INFLAMMATORY COMPOUNDS AND / OR TNF MODULATORS, METHOD OF MANUFACTURING THEREOF, PHARMACEUTICAL COMPOSITIONS THEREFOR AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY DISEASES
CR11684A (es) Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
CL2007002169A1 (es) Compuestos derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso del compuesto para prevenir o tratar la inflamacion, trastornos urologicos, gastrointestina
UY32820A (es) Composiciones dermatologicas de antagonistas del receptor dp2
CR9347A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
WO2009147201A3 (en) Anti-inflammatory agents
WO2007025632A3 (en) Nitrooxy derivatives op glucocorticoids
WO2008012338A3 (en) Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions
WO2011014825A3 (en) Antiangiogenic small molecules and methods of use
UY33530A (es) Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias
DK2022504T3 (da) Salve til behandling af hæmorider
BR112012022243A8 (pt) Uso de um inibidor de autofagia baseado em tioxantona e de um composto indutor de autofagia para terapia de câncer, composição farmacêutica e kit farmacêutico
BRPI0607795A2 (pt) compostos antiinflamatórios
BRPI0818822A2 (pt) Forma amorfa de um composto anti-inflamatório
BR112012029697A2 (pt) polissacarídeo da semente de tamarindo para uso no tratamento de doenças inflamatórias
DE102009018133A8 (de) Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.